Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 18

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 205–216 of 391 articles

Medium impact NewsJun 1, 2026

FDA's Permanent Ban on Compounded GLP-1s: What It Means for Pharma

FDA · GLP-1 · 3 min

Dr. Sarah Mitchell
Medium impact NewsJun 1, 2026

FDA Eases Restrictions on Peptides: Implications for Drug Approvals

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsJun 1, 2026

FDA Guidance on Next-Gen Sequencing for Gene Therapy Safety

FDA · gene therapy · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 31, 2026

FDA's Restructuring Opportunity Amid China Competition

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 31, 2026

5 FDA Drug Approvals to Watch in 2026

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 31, 2026

altRx GLP-1 Review 2026: FDA Updates on Semaglutide

FDA · GLP-1 · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 31, 2026

Pennsylvania Compounding Pharmacy Receives FDA Warning Letter

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 31, 2026

Wockhardt Secures US FDA Approval for ZAYNICH: A Milestone for Indian Pharma

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 31, 2026

Replimune's Third FDA Approval Attempt and Pfizer's China Deal

FDA · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 31, 2026

Friday Five: Key Regulatory Updates in Pharma

FDA · hepatitis · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 31, 2026

Zydus Lifesciences Secures FDA Priority Review for Liver Disease Drug

FDA · liver disease · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 31, 2026

FDA Device Guidance Agenda: Key Regulatory Updates for 2026

FDA · 3 min

Dr. Sarah Mitchell